BIDMC scientists developed a trivalent mRNA TB vaccine that outperformed the old BCG shot in mice and is moving toward Phase 1 human trials.

Power Vermont news today. Join at $14/month to keep trusted reporting free and enter to win a $250 Johnson Woolen Mills gift card. Senior Manufacturing Science Associate Diane Morgan performs an ...

When news of the efficacy of the Covid-19 vaccine was first shared, the medical community was astounded not only by the vaccine’s ability to protect people from infection but also by the speed at ...

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Invivyd, Inc. has submitted a Citizen Petition to the FDA advocating for a new approach to the development of COVID-19 vaccines and monoclonal antibodies (mAbs) to restore public trust in health ...

Scientists at Scripps Research have developed a novel method that uses artificial intelligence (AI) and advanced imaging ...

The Indian scientific community has achieved a historic milestone by creating AdFalciVax as the nation's first homegrown ...

Tracking vaccine effectiveness is essential for public health. Traditional monitoring methods, however, often rely on slow and infrequent data collection. Advances in healthcare technology (healthtech ...

Tuberculosis, or TB, an airborne bacterial respiratory infection, is one of humanity's oldest foes and is today the world's ...